ALIBX
Price
$13.22
Change
+$0.03 (+0.23%)
Updated
Oct 17 closing price
Net Assets
12.75M
RLBGX
Price
$39.04
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

ALIBX vs RLBGX

Header iconALIBX vs RLBGX Comparison
Open Charts ALIBX vs RLBGXBanner chart's image
ALPS/Smith Balanced Opportunity I
Price$13.22
Change+$0.03 (+0.23%)
VolumeN/A
Net Assets12.75M
American Funds American Balanced R6
Price$39.04
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
ALIBX vs RLBGX Comparison Chart in %
View a ticker or compare two or three
VS
ALIBX vs. RLBGX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALIBX is a Hold and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 265B vs. ALIBX (12.8M). RLBGX pays higher dividends than ALIBX: RLBGX (2.05) vs ALIBX (1.62). ALIBX was incepted earlier than RLBGX: ALIBX (5 years) vs RLBGX (16 years). ALIBX (2.64) is less costly to investors than RLBGX (0.25). ALIBX is a more actively managed with annual turnover of: 131.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than ALIBX: RLBGX (250) vs ALIBX (2500). RLBGX annual gain was more profitable for investors over the last year : 9.08 vs. ALIBX (-0.46). RLBGX return over 5 years is better than : 44.16 vs. ALIBX (38.32).
ALIBXRLBGXALIBX / RLBGX
Total Expense Ratio1.150.25460%
Annual Report Gross Expense Ratio2.640.251,056%
Fund Existence5 years16 years-
Gain YTD9.70814.95165%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.8M265B0%
Annual Yield % from dividends1.622.0579%
Returns for 1 year-0.469.08-5%
Returns for 3 years38.6452.0274%
Returns for 5 years38.3244.1687%
Returns for 10 yearsN/A79.32-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACIW48.750.57
+1.18%
ACI Worldwide
FRST9.650.06
+0.63%
Primis Financial Corp
INVA17.270.02
+0.12%
Innoviva
CLGN2.32-0.02
-0.64%
CollPlant Biotechnologies Ltd
BCS19.36-0.59
-2.96%
Barclays PLC